17 Studies were reviewed, Conclusion: the most reasonable risk estimate seems still to be the relative risk of 1.4 derived from the hitherto methodologically most convincing study by Knutsson et al. whose results are supported by the demonstration of a dose-response and an equal risk for both genders.